Cargando…

Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa

OBJECTIVES: The cephalosporin nitric oxide (NO)-donor prodrug DEA-C3D (‘DiEthylAmin-Cephalosporin-3′-Diazeniumdiolate’) has been shown to initiate the dispersal of biofilms formed by the Pseudomonas aeruginosa laboratory strain PAO1. In this study, we investigated whether DEA-C3D disperses biofilms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soren, Odel, Rineh, Ardeshir, Silva, Diogo G, Cai, Yuming, Howlin, Robert P, Allan, Raymond N, Feelisch, Martin, Davies, Jane C, Connett, Gary J, Faust, Saul N, Kelso, Michael J, Webb, Jeremy S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910178/ https://www.ncbi.nlm.nih.gov/pubmed/31682251 http://dx.doi.org/10.1093/jac/dkz378

Ejemplares similares

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
por: Howlin, Robert P., et al.
Publicado: (2017)

Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosa clinical isolates
por: Cai, Yu-ming, et al.
Publicado: (2020)

Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug
por: Wang, Yuqiang, et al.
Publicado: (2001)

Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
por: van Haren, Matthijs J., et al.
Publicado: (2021)

Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
por: Barnes, Melissa D., et al.
Publicado: (2018)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Role of inducers in detection of bla(PDC)-mediated oxyimino-cephalosporin resistance in Pseudomonas aeruginosa
por: Ingti, Birson, et al.
Publicado: (2017)

Effects of Lysozyme, Proteinase K, and Cephalosporins on Biofilm Formation by Clinical Isolates of Pseudomonas aeruginosa
por: Eladawy, Mohamed, et al.
Publicado: (2020)

Survey of Blood Groups DEA 1, DEA 4, DEA 5, Dal, and Kai 1/Kai 2 in Different Canine Breeds From a Diagnostic Laboratory in Germany
por: Ebelt, Anne K., et al.
Publicado: (2020)

Chemical Exposures: Will DEA Findings Wash?
por: Washam, Cynthia
Publicado: (2006)

Dr. Charles A. O’Dea
Publicado: (1918)

Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide
por: Zhou, Hui-fang, et al.
Publicado: (2014)

Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing
por: Gajdács, Márió
Publicado: (2020)

Cephalosporins Interfere With Quorum Sensing and Improve the Ability of Caenorhabditis elegans to Survive Pseudomonas aeruginosa Infection
por: Kumar, Lokender, et al.
Publicado: (2021)

Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control
por: Evans, Michael A., et al.
Publicado: (2018)

Etymologia: Cephalosporin
Publicado: (2005)

Does Cephalosporin Skin Test Predict Immediate Hypersensitivity to Cephalosporin?
por: Choi, Jeong-Hee
Publicado: (2019)

Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K
por: Sjödin, Birgitta, et al.
Publicado: (2021)

Cohort Profile: The German Ageing Survey (DEAS)
por: Klaus, Daniela, et al.
Publicado: (2017)

A DEA model for measuring financial intermediation
por: Boďa, Martin, et al.
Publicado: (2020)

Congestion in multi-function parallel network DEA
por: Kassaei, Sarvar Sadat, et al.
Publicado: (2023)

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
por: Green, Laura K, et al.
Publicado: (2013)

Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release
por: Meiers, Joscha, et al.
Publicado: (2022)

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa
por: Ito, Akinobu, et al.
Publicado: (2016)

Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins
por: Zaidenstein, Ronit, et al.
Publicado: (2018)

Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil
por: Campana, Eloiza Helena, et al.
Publicado: (2016)

Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide
por: Winther, Anna K., et al.
Publicado: (2018)

Differential impact on motility and biofilm dispersal of closely related phosphodiesterases in Pseudomonas aeruginosa
por: Cai, Yu-ming, et al.
Publicado: (2020)

Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer
por: Kim, Taejeong, et al.
Publicado: (2022)

Cephalosporin-resistant typhoid
por: Pereira, Noella Maria Delia, et al.
Publicado: (2020)

Modeling performance measurement: applications and implementation issues in DEA
por: Cook, Wade D, et al.
Publicado: (2005)

Conference on New Uses of DEA in Management and Public Policy
por: Charnes, Abraham, et al.
Publicado: (1994)

Parametric modeling with I-DEAS Master Series 7 /
por: Shih, Randy H.
Publicado: (1999)

Assessment of productivity of hospitals in Botswana: a DEA application
por: Tlotlego, Naomi, et al.
Publicado: (2010)

Health in older age: The German Ageing Survey (DEAS)
por: Wurm, Susanne, et al.
Publicado: (2013)

Multi-level DEA for the construction of multi-dimensional indices
por: Tsaples, Georgios, et al.
Publicado: (2020)

Hypermutator strains of Pseudomonas aeruginosa reveal novel pathways of resistance to combinations of cephalosporin antibiotics and beta-lactamase inhibitors
por: Dulanto Chiang, Augusto, et al.
Publicado: (2022)

Encapsulated Methionine γ-Lyase: Application in Enzyme Prodrug Therapy of Pseudomonas aeruginosa Infection
por: Morozova, Elena, et al.
Publicado: (2020)

New Methods for the Synthesis of Spirocyclic Cephalosporin Analogues
por: Zhao, Alan X., et al.
Publicado: (2021)

Mucins trigger dispersal of Pseudomonas aeruginosa biofilms
por: Co, Julia Y., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jpcn6smkrt2ab8hsii7iesmvsv